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Intraepithelial lymphocytes (IEL) comprise a  large heterogeneous population 
of immune cells located in the intestinal epithelium of man and rodents. Specific 
mechanisms of IEL-mediated immunity are  not  well  defined,  due  in  part  to 
difficulties in isolating IEL subsets, and in part to the rather arcane nature of 
the IEL themselves. Two fundamental characteristics distinguish the IEL from 
cells of other peripheral  immune compartments.  First,  phenotypic studies of 
isolated murine IEL show that 80-90%  of the cells are Lyt-2  + lymphocytes, of 
which about half bear Thy-1 + surface antigens (1,  2). The origin and functional 
role of the Thy-l-, Lyt-2  ÷ IEL are largely unknown (1). It has been proposed 
(3,  4)  that some or all  of those cells represent a  thymus-independent type of 
effector  IEL,  though  formal  evidence  for  this  has  not  been  demonstrated. 
Secondly, murine IEL isolates are characterized as having a  variety of natural 
effector activities. These include cytotoxic activities mediated by NK cells (1,  2, 
5, 6),  spontaneous cytotoxic (SC) cells  (6),  and natural cytotoxic (NC) cells  (2). 
The relationship of those effector responses to the Thy-l-, Lyt-2  + IEL is un- 
certain. 
The present study has characterized IEL according to the expression of murine 
lymphocyte antigenic markers, including three surface antigens not previously 
identified on IEL. As reported here, in both thymus-bearing and athymic nude 
mice, an unusually high proportion of IEL from unprimed animals expressed an 
antigen associated with activated cytotoxic cells and a lymphocyte marker present 
on immature T  cells. These findings directly address issues of IEL ontogeny and 
function, and  provide  evidence  that  some  cytotoxic IEL  may originate by  a 
thymus independent lineage. 
Materials and Methods 
Mice.  Female BALB/cBy mice, 8-10  wk of age,  were obtained from The Jackson 
Laboratories,  Bar Harbor, ME. Athymic nude mice (nu/nu) of BALB/c background,  8- 
10 wk of age, were purchased  from the Athymic Nude Facility, UCSD. 
Monoctonal  Antibodies.  mAb against murine lymphocyte surface antigens used in these 
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FIGURE  i.  Size  distribution of IEL from normal and athymic nude mice as determined by 
flow cytometry analyses. Arrows indicate separation of small (left of arrow) and large (right of 
arrow) IEL populations. 
experiments were as follows: H0.13.4 (7), anti-Thy 1.2; AD4(15) (8), anti-Lyt 2.2; GK 1.5 
(9), anti-L3T4; CT-1 (10), anti-CT; and J1 ld (11), antilymphocyte. 
Isolation oflEL.  Procedures used to isolate intestinal  IEL have been previously de- 
scribed (12). These consist of an EDTA-extraction of the intestinal epithelium and IEL, 
followed by density gradient separations on  Percotl (1).  As determined from paraffin- 
embedded tissue sections, this procedure permits isolation of IEL without penetration 
into the lamina propria layer. 
Flow Cytometry Analysis of Cell Surface Antigens.  Analyses of  lymphocyte surface markers 
were done by indirect immunofluorescence, using the primary mAb listed above, followed 
by FITC-conjugated rabbit anti-mouse or rabbit anti-rat immunoglobulin. Stained cells 
were analyzed on an Ortho Cytofluorograph, system 50-H (Ortho Diagnostics,  Westwood, 
MA). 
Assay for Cytotoxic Activity.  Percoll-passed IEL effector cells and dilutions were added 
in  100 tA to 96-well  microtiter plates.  5ZCr-labelled target cells (P815 or YAC-1)  were 
added to effector cells in 100 t~l at a final concentration of 104 targets cells/well. Cultures 
were incubated for 4  h  at  37°C  in  5%  COe.  Complement-mediated depletion of IEL 
subsets was done by incubating 20-30 x  106 IEL with monoclonal anti-CT (1/100 dilution 
of ascites) or anti-J 11 d (undiluted tissue culture supernatant) for 45 min at 4 o  C, followed 
by rabbit complement (l/10 dilution) at 37 °C for 45 min. Treated IEL were passed through 
Ficoll-Hypaque, and viable cells were assayed for cytotoxic activity. Specific lyses were 
determined as follows: percent specific lysis =  100 x  [cpm release experimental group) - 
(cpm spontaneous release)]/[(cpm after detergent lysis) -  (cpm spontaneous release)]. 
Results 
Expression  of T Lymphocyte Antigens on Intestinal IEL.  Percoll-fractionated IEL 
and splenic lymphocytes from unprimed normal and nude mice were studied by 
flow cytometry analyses for the expression of Thy-1, Lyt-2, L3T4,  CT-1,  and 
J1 l d  surface antigens.  IEL were analyzed on the cell sorter according to small 
and  large  cell  populations,  (Fig.  1).  Small  IEL,  which  were  similar  in  size  to 
resting splenic or lymph node lymphocytes, made up 44%  of normal  IEL and 
38% of nude IEL (Table I).  Large IEL were two to four times the size of small 
IEL,  and  comprised  56%  of normal  and  62%  of nude  IEL.  Small  IEL  from 
thymus-bearing mice were predominantly Lyt-2  +, L3T4- lymphocytes, of which 
about  half possessed  Thy-I  surface  antigens.  In  contrast,  98%  of large  IEL, 
although also Lyt-2  + and L3T4-, did not express Thy-1 surface antigens. Thus, 
nearly 70% of the IEL, overall, were Thy-l-, Lyt-2  +,  L3T4- cells. Spleen cells 
from athymic nude mice were essentially void of Thy-1 + and Lyt-2  + lymphocytes, 
whereas IEL from nude mice, which were also Thy-l-, were Lyt-2  + for approx- 
imately half the cells. The data pertaining to Thy-1 and Lyt-2 expression on IEL 
correlate with findings of others (1, 2) describing the distribution of those T  cell KLEIN  BRIEF  DEFINITIVE  REPORT  311 
TABLE  I 
Cell Surface Antigens on Intestinal and Splenic Lymphocytes  from Nude and 
Thymus-bearing Mice 
Mouse 
Lympho-  Cell  Percent of  Percentage of cells expressing:* 
cyte source  population  IEL  Thy-I  L3T4  Lyt-2  CT-I  J1 ld 
Normal  Spleen  Small  --  29 ±  7  ND  ND  3 -  2  66 ±  9 
IEL  Small  44 4- 3  63 +  3  6 4- 3  90 ±  6  55 +  7  17 ±  6 
IEL  Large  56±7  3±2  !  ±  1  82±5  52±4  60±  II 
Nude  Spleen  Small  --  2  ±  2  1 ±  1  2 ±  2  9  ±  7  91 ±  5 
IEL  Small  38±6  lzk2  3±1  56±10  61±5  62±11 
IEL  Large  62±4  2±  1  2±2  48±  18  78±6  48±8 
* As determined  by  flow cytometry analyses.  Data  represent  mean  values  +-  SEM  of  3-5  experiments,  each 
consisting of pooled IEL isolates from four mice. 
markers  on  murine  IEL,  and  are  important  because  they  indicate  that  IEL 
isolates used in the following experiments represent typical IEL populations. 
IEL Express a Cytotoxic Activation Antigen and an Antigen Associated with Immature 
T Cells.  The most surprising findings of these studies pertain to the level of CT 
and J 1 ld antigen expression on IEL. 50-60% of both large and small IEL from 
thymus-bearing  mice  expressed  the  CT-1  cytotoxic activation  antigen.  CT-1 
antigens were also present on IEL from nude mice to a level equivalent to that 
found on IEL of thymus-bearing animals.  In contrast to the IEL, <3% of spleen 
cells  from  thymus-bearing  mice  were  CT-1 +,  a  finding  consistent  with  other 
studies (10) of the expression of CT antigens  in murine  spleen cells of normal 
unprimed  mice.  Similarly,  in  thymus-bearing  mice,  the  majority  of large  and 
some small IEL were J1 ld+; in nude mice, roughly half of both small and large 
IEL were J1 ld +. Since >95% of the large IEL in thymus-bearing mice were Thy- 
1- cells, J1 ld must be expressed primarily on a Thy-l-,  Lyt-2  + IEL population. 
J l ld antigen expression on unfractionated  spleen cells was consistent with that 
reported  by others  (11),  and  as expected,  nearly all  splenic  lymphocytes from 
nude mice were J1 ld +. 
Natural  Effector  Activities  Present  in  IEL  Isolates  are  Associated  with  CT  + and 
Jl ld + Subsets.  To determine whether CT  + and J 1 l d ÷ IEL subsets were associ- 
ated with  functional  IEL effector populations,  fresh  IEL  isolates were treated 
with antibody (CT-1 or J 11 d) plus complement before assay for cytotoxic activity 
against YAC-I  (NK-sensitive) and P815 (SC-sensitive) target cells. Both NK and 
SC cytotoxic activities present in IEL isolates were abrogated by treatment with 
either  CT-1  or  J1 I d  antibodies  (Fig.  2),  indicating  that  both  antigens  are 
associated in some way with cytotoxic effector populations of the IEL. Although 
J1 ld is specific for nearly all  B cells (see Discussion), the finding that J1 ld was 
expressed on cytotoxic IEL rules out the possibilities that J 11 d + IEL are B cells 
present in the intestinal  epithelium, or that  IEL isolates had been contaminated 
with B cells. 
Discussion 
The Thy-l-,  Lyt-2  + type of IEL constitutes a  large proportion  (50-70%) of 
the total IEL, as demonstrated here and as reported by others (1,2, 14). However, 
the ontogeny and functional  nature of this cell type is a  matter of controversy. 312  KLEIN  BRIEF  DEFINITIVE  REPORT 
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F[CURE  2.  Abrogation of cytotoxic activities mediated by SC (P815 target) and N K (YAC-1 
target) cell populations following treatment of IEL with CT-I antibody (O) or J1 ld antibody 
(A) plus complement. Complement control without specific antibody (0). 
On  the  one  hand,  it  has  been  proposed  that  those  IEL  represent  thymus- 
independent cells that have acquired ]ytic activity upon maturation within the 
intestinal epithelium (3, 4). Alternatively, the Thy-l-, Lyt-2  + IEL may be derived 
from peripheral CTL that have lost Thy-1 antigen expression. 
The finding that more than half of all IEL from unprimed mice express the 
cytotoxic activation antigen, CT-1, indicates that, as a group, the IEL consist of 
a  population of cytotoxic cells  that are  highly activated and presumably lytic. 
Because spleen cells from the same animals used for IEL studies were predomi- 
nantly CT-I-, similar to what has been reported by others (10) for normal spleen 
cells,  it appears that the intestinal epithelium represents a site uniquely enriched 
for activated cytotoxic cells.  The presence of CT-1  antigens on Thy-l-, Lyt-2  + 
IEL from thymus-bearing mice (e.g., large IEL) is important in several ways. It 
shows that CT antigens can be associated with a population of Thy-1- as well as 
Thy-1 + cytotoxic cells.  It also suggests that some effector IEL may represent a 
thymus-independent type of IEL.  However, the data do not formally rule out 
the possibility that  those  IEL originated from  Thy-1 + peripheral  CTL.  More 
convincing evidence of a thymus-independent origin for the Thy-l-, Lyt-2  + IEL 
comes from the data pertaining to CT antigen expression on nude IEL, where 
60-70% of the IEL were CT-1 + and Thy-1-. The presence of Lyt-2 antigens on 
IEL  but  not  on  splenic  lymphocytes from  nude  mice  further  implicates  the 
intestinal epithelium as a site of local activation of non-thymus-derived cytotoxic 
precursors. Moreover, the finding that CT-1  antigen is expressed on nude IEL 
correlates with observations by others (13) that nude IEL possess  lyric activity to 
NK-sensitive target cells. 
J1 ld expression on  IEL was unexpected, since J1 ld is a  murine lymphocyte 
marker associated with B cells and is not present on mature or activated T  cell 
populations (11). J1 ld is, however, present on some immature T  cells,  notably 
on cortical thymocytes (11).  That J] ld on  IEL reflects a T  cell marker rather 
than a  B  cell  marker  is suggested in  the  fbllowing ways.  First,  it  is generally 
accepted that IEL are essentially void of B cells; <5% of the IEL bear surface Ig 
(J. R. Klein, unpublished observation, and ref.  14). Consistent with that fact are 
the observations in the present study that nearly all IEL were either Lyt-2  + (80- 
90%) or  L3T4  + (6-8%)  cells,  and as such, J1 ld must be expressed on one or KLEIN  BRIEF  DEFINITIVE REPORT  313 
both of those IEL subsets. Second, IEL depleted of  J1 ld + cells lost lytic activity 
mediated  by NK and  SC effector populations,  indicating  that J1 ld + IEL were 
associated with  a  population  of lytically active cells.  These  findings,  which  for 
the first time link J1 l d  antigen  expression to functional  cytotoxic Lyt-2  + cells, 
although seemingly incompatible with current knowledge ofJ 1 ld expression on 
lymphocytes, may not be incongruent when considering the biology of the IEL. 
Rather,  the  data  are  taken  to  indicate  that  the J1 ld + cell  reflects  a  thymus- 
independent type of IEL, i.e., an "immature" T  cell that has acquired lytic activity 
within the intestinal epithelium, and has retained the J 1 ld surface marker.  This 
interpretation  applies most notably to the  large  IEL,  which are primarily  Thy- 
1- cells. However, when all 1EL were simultaneously stained for Thy-1 and J1 ld 
antigens  using a  double staining  technique,  <5%  of the  IEL were positive for 
both Thy- 1 and J 11 d antigens (data not shown), suggesting that Thy- 1 and J 11 d 
are distributed on discrete IEL subsets. Thus, by inference, a substantial propor- 
tion of the IEL must be Thy-l-,  Lyt-2  ÷, L3T4-, J1 ld + cells with lytic activity. 
Taken  together,  the findings  reported here suggest that  some IEL originate 
as  non-thymus-derived  cells  that  acquire  lyric  activity  presumably  within  the 
intestinal  epithelium  itself.  Local  activation  of effector  ceil  precursors  could 
occur upon exposure to T  cell-derived lymphokines such as IL-2. IL-2 has been 
shown to induce IEL-derived cytotoxic clones to express NK lytic activity (I 2). 
Moreover, a mechanism of effector activation such as this would explain recent 
observations (6) which show that, during an antigen-specific CTL response within 
the  intestinal  mucosa,  NK  and  SC  cytotoxic activities  are  simultaneously  in- 
creased. Finally, it should be noted that the observations described here now can 
be addressed through molecular studies of T  cell receptor gene rearrangements, 
particularly with respect to the Thy-l-, Lyt-2  ÷, J1 ld + cytotoxic IEL. 
Summary 
Murine  intestinal  intraepithelial  lymphocytes (IEL)  from  unprimed  thymus- 
bearing and athymic nude mice were characterized according to the expression 
of murine lymphocyte antigenic markers and cytotoxic activity. The majority of 
IEL from thymus-bearing  mice were Lyt-2  +,  L3T4-  lymphocytes, over half of 
which did not express Thy-1  surface antigens.  Nude IEL and spleen cells were 
void of Thy-1 + cells; however,  Lyt-2 antigens  were expressed on a  significant 
proportion  of IEL, but not splenic lymphocytes. Overall,  40-70%  of IEL from 
either thymus-bearing  or athymic mice expressed the cytotoxic activation anti- 
gen, CT-1, and the J 11 d lymphocyte marker, both of which were associated with 
a population of Thy-1-, Lyt-2  + cytotoxic IEL. These data are taken to mean that 
the intestinal  epithelium is a site uniquely enriched  for activated cytotoxic cells, 
a significant proportion  of which originate as non-thymus-derived lymphocytes 
with acquired lytic activity. 
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